Kenvue
Prix: 18.14Entreprise et modèle économique
Kenvue (KVUE.US) operates in the consumer staples sector, focusing on personal care and hygiene products. Its core offerings include over-the-counter medications, skincare, and household cleaning products. Major business segments encompass health and wellness, beauty, and home care, with primary revenue sources derived from product sales in retail and e-commerce channels.
Profil d’investissement
The investment profile of Kenvue is more aligned with dividend investors due to its notable dividend yield of 6.0%. The stock exhibits moderate growth potential, making it suitable for those seeking a balance between income and capital appreciation. Its relatively stable performance and low volatility suggest a lower risk profile, appealing to investors with a medium to long-term horizon.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 0.85 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 3.4% ↑
- Surprise BPA
- 18.5% meilleur que prévu
- Volatilité 20 j
- 1.6% stable
- Rendement du dividende
- 4.6% élevé dernière date ex-dividende: 2026-05-13
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-10 00:48 | Conserver | Acheter | Strong fundamentals and solid dividend yield support growth. |
| 2026-05-30 02:43 | Acheter | Conserver | Stable dividend, but weak momentum and high risk. |
| 2026-05-22 02:50 | Conserver | Acheter | Stable dividend, moderate growth, mixed momentum signals. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-04-14 12:53 | Barclays | Objectif abaissé | 19 → 18 | 17.385 |
| 2026-02-18 12:42 | UBS | Objectif relevé | 17 → 19 | 18.41 |
| 2026-02-18 12:10 | Canaccord Genuity | Objectif relevé | 17 → 18 | 18.41 |
Rien pour le moment